Immunogenicity of ND1.1 by Delivery Directly to the Ileum

NCT01698060 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vaxart